Allogeneic hematopoietic cell transplantation survivors are at a higher risk of death than the general population

Chronic graft-versus-host disease by 2 years is a strong risk factor for late mortality

Risk of mortality due to respiratory/renal cause is high 2 decades after allogeneic hematopoietic cell transplantation

Risk of mortality due to new nonhematological cancer is high among hematopoietic cell transplantation survivors